Related Experiment Videos
Sinonasal undifferentiated carcinoma: an update
1Department of Otolaryngology, Head and Neck Surgery, University of California-Davis, 2521 Stockton Boulevard, Sacramento, CA 95817, USA. danny.enepkides@ucdmc.ucdavis.edu
Summary
Aggressive multimodality treatment, including platinum-based chemotherapy and radiation, offers improved outcomes for sinonasal undifferentiated carcinoma (SNUC). This approach enhances locoregional control and survival for this rare and malignant tumor.
Area of Science:
- Oncology
- Otorhinolaryngology
- Head and Neck Surgery
Background:
- Sinonasal undifferentiated carcinoma (SNUC) is a rare, highly malignant tumor.
- Historically, SNUC has been associated with poor treatment outcomes.
- Recent advancements focus on improving locoregional control and survival rates.
Purpose of the Study:
- To review current management strategies for SNUC.
- To examine treatment trends impacting SNUC outcomes.
- To identify factors contributing to improved survival in SNUC patients.
Main Methods:
- Review of recent data on SNUC management.
- Analysis of treatment trends and their impact on outcomes.
- Evaluation of multimodality treatment approaches.
Main Results:
- Aggressive multimodality treatments correlate with improved patient outcomes.
- Preoperative or postoperative chemoradiotherapy with platinum-based agents shows promise for disease-free survival.
- Optimal surgical timing in SNUC treatment remains under investigation.
Conclusions:
- Overall outcomes for SNUC remain poor.
- An aggressive treatment strategy combining surgery, platinum-based chemotherapy, and radiation offers the best chance for significant locoregional control and survival.
- Further research is needed to refine treatment protocols for SNUC.